Reddout Mark sold $300K of INVX

Reddout Mark (President of North America) sold 10,000 shares of Innovex International, Inc. (INVX) at $30.00 ($0.30M total) on 2026-08-04 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Reddout Mark
Published Aug 5, 2026, 10:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 5, 2026, 10:02 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$INVX
Neutral
high confidence
Mentioned
$INVX
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$INVXNeutralLow
01

Why it matters

The newest fact is the specific sale size ($300,000) and that it was executed under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note insider selling, but the 10b5-1 structure makes it less likely to drive a durable repricing without additional news.

03

What to watch

The filing does not disclose reasons for the sale, and the post-transaction holdings (124,312 shares) suggest the insider did not exit the position.

Relevance 3/10Novelty 2/10Timing: filed 2026-08-05, transaction dated 2026-08-04

Background

The article is an SEC Form 4 insider transaction disclosure for Innovex International, Inc. (INVX).

Company-level read

Ticker impact

$INVXNeutralHigh confidence
Context

Form 4 shows INVX President of North America Reddout Mark sold 10,000 shares for $300,000 on an open-market sale under a 10b5-1 plan.

Expected impact

Limited near-term impact; any reaction is likely noise unless paired with other company-specific news.

Evidence & confidence

The filing is a Form 4 insider transaction with a stated 10b5-1 pre-arranged plan, which typically reduces interpretive signal versus discretionary selling.

Market effects

No sector-level implications; this is company-specific insider transaction reporting.

None indicated.

None indicated.

Counterpoint

Because the sale is under a 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • Innovex International, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Reddout Mark

    President of North America who sold 10,000 shares of INVX.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$INVXMedAI 8/10

Innovex (INVX) Q3 2026 Earnings Call Transcript

Innovex (INVX) reported Q3 2026 revenue of $265M, up 8% sequentially and 10% YoY, with adjusted EBITDA of $55M (21% margin). The company highlighted growth in North America, offshore, and Middle East, with new contracts in Venezuela and the North Sea. Innovex expects continued growth in 2027-2028, driven by subsea projects and market share gains. Free cash flow was $32M, 58% of adjusted EBITDA.

$INVXHigh

Innovex Announces Third Quarter 2026 Results

Innovex International, Inc. (INVX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Innovex Announces Third Quarter 2026 Results HOUSTON, October 29, 2026 – Innovex International, Inc. (NYSE: INVX) (“Innovex,” the “Company” or “we”) today announced financial and operating results for the third quarter of 2026. Third Quarter Highlights • Revenue of $265 million,

$INVXMedAI 8/10

Innovex (INVX) Q2 2026 Earnings Call Transcript

Innovex (INVX) reported Q2 2026 revenue of $245 million, up 2% sequentially and 9% year over year, with adjusted EBITDA of $48 million (20% margin) and free cash flow of $30 million. Management cited international/offshore growth and Mexico activity, plus a $95 million TCO Group acquisition completed July 1. Q3 guidance calls for $260 million to $270 million revenue and $51 million to $57 million adjusted EBITDA.